# Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review

## TL;DR

This review explores strategies to improve lung utilization from different types of donors to address the shortage of transplantable lungs.

## Contribution

The paper provides tailored, evidence-based strategies for managing donor lungs from DBD, cDCD, and uDCD donors.

## Key findings

- Protective ventilation and early bronchoscopy are critical for DBD donor lungs.
- cDCD donor lungs benefit from optimized pre- and post-withdrawal management.
- uDCD donor lungs require EVLP for effective preservation due to prolonged ischaemia.

## Abstract

Lung transplantation remains the standard of care for end-stage lung disease, yet a persistent gap exists between donor lung availability and growing clinical demand. Expanding the donor pool and optimising donor lung management are therefore critical priorities. However, no universally accepted management protocols are currently in place. This narrative review examines evidence-based strategies to improve lung utilisation across three donor categories: donors after brain death (DBD), controlled donors after circulatory death (cDCD), and uncontrolled donors after circulatory death (uDCD). A systematic literature search was conducted to identify interventions targeting lung preservation and function, including protective ventilation, recruitment manoeuvres, fluid and hormonal management, and ex vivo lung perfusion (EVLP). Distinct pathophysiological mechanisms—sympathetic storm and systemic inflammation in DBD, ischaemia–reperfusion injury in cDCD, and prolonged warm ischaemia in uDCD—necessitate tailored approaches to lung preservation. In DBD donors, early application of protective ventilation, bronchoscopy, and infection surveillance is essential. cDCD donors benefit from optimised pre- and post-withdrawal management to mitigate lung injury. uDCD donor lungs, uniquely vulnerable to ischaemia, require meticulous post-mortem evaluation and preservation using EVLP. Implementing structured, evidence-based lung management strategies can significantly enhance donor lung utilisation and expand the transplantable organ pool. The integration of such practices into clinical protocols is vital to addressing the global shortage of suitable lungs for transplantation.